Benzinga | Feb 25, 2021 11:09AM EST

Piper Sandler Maintains Overweight on Teladoc Health, Lowers Price Target to $291

Piper Sandler analyst Sean Wieland maintains Teladoc Health (NYSE:TDOC) with a Overweight and lowers the price target from $305 to $291.